Chlorambucil

  • Robert B. Livingston
  • Stephen K. Carter

Synonyms

Leukeran CB-1348 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. (1).
    Galton, D., Israels, L., Nabarro, J., and Till, M. Clinical trials of p-(di-2-chloroethyl-amino)-phenylbutyric acid (CB 1348) in malignant lymphoma. Brit Med J 2: 1172, 1955.PubMedCrossRefGoogle Scholar
  2. (2).
    Bouroncle, B., Doan, C., Wiseman, B., and Frajola, W. Evaluation of CB 1348 in Hodgkin’s disease and allied disorders. Arch Intern Med 97: 703, 1956.CrossRefGoogle Scholar
  3. (3).
    Bernard, J., Mathe, G., and Weil, M. Therapeutic trial with para-(di-2-chloroethylamino)-phenylbutyric acid in Hodgkin’s disease, chronic lymphoid leukemia and various sarcomas of the lymphoid tissue. (Study on 100 patients). Rev Franc Et Clin Biol 1: 1121, 1956.Google Scholar
  4. (4).
    Altman, S., Haut, A., Cartwright, G., and Wintrobe, M. Early experience with p-(N, N-di-2-chloroethyl)-aminophenylbutyric acid (CB 1348), a new chemotherapeutic agent effective in the treatment of chronic lymphocytic leukemia. Cancer 9: 512, 1956.PubMedCrossRefGoogle Scholar
  5. (5).
    Shanbrom, E., Knudson, A., and Rapaport, S. Clinical evaluation of chlorambucil. Clin Res Proc 5: 31, 1957.Google Scholar
  6. (6).
    Rottino, A. Therapeutic results in treatment of Hodgkin’s disease with CB 1348 and R-48. Blood 12: 755, 1957.PubMedGoogle Scholar
  7. (7).
    Hansen, P. Clinical experience with CB 1348 in the treatment of chronic lymphatic leukaemia. Acta Radiol 47: 210, 1957.PubMedCrossRefGoogle Scholar
  8. (8).
    Gumport, S., Golomb, F., and Wright, J. Summary of results obtained with CB 1348. Ann N Y Acad Sci 68: 1024, 1958.PubMedCrossRefGoogle Scholar
  9. (9).
    Olson, K. P-(di-2-chloroethyl) aminophenylbutyric acid (CB 1348) in the treatment of cancer. Ann N Y Acad Sci 68: 1017, 1958.PubMedCrossRefGoogle Scholar
  10. (10).
    Ultmann, J., Hyman, G., and Gellhorn, A. Chlorambucil and triethylene thiophosphoramide in the treatment of neoplastic disease. Ann N Y Acad Sci 68: 1007, 1958.PubMedCrossRefGoogle Scholar
  11. (11).
    Doan, C., Wiseman, B., and Bouroncle, B. Clinical evaluation of CB 1348 in leukemias and lymphomas. Ann N Y Acad Sci 68: 979, 1958.PubMedCrossRefGoogle Scholar
  12. (12).
    Israels, L., Galton, D., Till, M., and Wiltshaw, E. Clinical evaluation of CB 1348 in malignant lymphoma and related diseases. Ann N Y Acad Sci 68: 915, 1958.PubMedCrossRefGoogle Scholar
  13. (13).
    Krakoff, I., Karnofsky, D., and Burchenal, J. Remissions induced by chlorambucil in chronic granulocytic leukemia. JAMA 166: 629, 1958.CrossRefGoogle Scholar
  14. (14).
    Rundles, R., Grizzle, J., Bell, W., et al. Comparison of chlorambucil and Myleran in chronic lymphocytic and granulocytic leukemia. Amer J Med 27: 424, 1959.CrossRefGoogle Scholar
  15. (15).
    Miller, D., Diamond, H., and Craver, L. The clinical use of chlorambucil. A critical study. New Eng J Med 261: 525, 1959.PubMedCrossRefGoogle Scholar
  16. (16).
    Masterson, J., Calame, R., and Nelson, J. A clinical study on the use of chlorambucil in the treatment of cancer of the ovary. Amer J Obstet Gyn 79: 1002, 1960.Google Scholar
  17. (17).
    Pinkel, D. Chlorambucil in childhood cancer. Cancer 14: 36, 1961.PubMedCrossRefGoogle Scholar
  18. (18).
    Galton, D., Wiltshaw, E., Szur, L., and Dacie, J. The use of chlorambucil and steroids in the treatment of chronic lymphocytic leukaemia. Brit J Haemat 7: 73, 1961.PubMedCrossRefGoogle Scholar
  19. (19).
    Clatanoff, D., and Meyer, 0. Response to chlorambucil in macroglobulinemia. JAMA 183: 40, 1963.PubMedGoogle Scholar
  20. (20).
    Bigley, R. Treatment of chronic lymphocytic leukemia with triethylene melamine (TEM) and chlorambucil (CB 1348). Cancer Chemother Rep 30: 27, 1963.PubMedGoogle Scholar
  21. (21).
    Kaung, D., Whittington, R., and Patno, M. Treatment of chronic lymphocytic leukemia with chlorambucil (NSC 3088) and cyclophosphamide (NSC 26271). Cancer Chemother Rep 39: 41, 1964.PubMedGoogle Scholar
  22. (22).
    Wiltshaw, E. Chlorambucil in the treatment of primary adenocarcinoma of the ovary. J Obstet Gynaec Brit Cmwlth 72: 586, 1964.CrossRefGoogle Scholar
  23. (23).
    Masterson, J., and Nelson, J. The role of chemotherapy in the treatment of gynecologic malignancy. Amer J Obstet Gynec 93: 1102, 1965.PubMedGoogle Scholar
  24. (24).
    Ezdinli, E., and Stutzman, L. Chlorambucil therapy for lymphomas and chronic lymphocytic leukemia. JAMA 191: 444, 1965.PubMedCrossRefGoogle Scholar
  25. (25).
    Keettel, W. The treatment of ovarian cancer. Ca 16: 245, 1966.PubMedGoogle Scholar
  26. (26).
    Degos, R., et al. Treatment of Kaposi’s disease with chlorambucil (chloramínophene). Dermatologica 135: 345, 1967.PubMedCrossRefGoogle Scholar
  27. (27).
    McCallister, B., Bayrd, E., Harrison, E., and McGuckin, W. Primary macroglobulinemia. Review with a report on thirty-one cases and notes on the value of continuous chlorambucil therapy. Amer J Med 43: 394, 1967.CrossRefGoogle Scholar
  28. (28).
    Moore, G., Bross, I., Ausman, R., et al. Effects of chlorambucil (NSC 3088) in 374 patients with advanced cancer. Cancer Chemother Rep 52: 661, 1968.PubMedGoogle Scholar
  29. (29).
    Kaung, D., Whittington, R., Spencer, H., and Patno, M. Comparison of chlorambucil and streptonigrin in the treatment of chronic lymphocytic leukemia. Cancer 23: 597, 1969.PubMedCrossRefGoogle Scholar

Copyright information

© IFI/Plenum · New York-Washington-London 1970

Authors and Affiliations

  • Robert B. Livingston
    • 1
  • Stephen K. Carter
    • 1
  1. 1.National Cancer InstituteBethesdaUSA

Personalised recommendations